SCHEMBL4201892

SCHEMBL4201892

CC(CC1CCCCC1)NCc1cnccc1NC(=O)Nc1cc2ccccc2s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
REN P00797 1/20 0.38
CNR1 P21554 2/20 0.36
CNR2 P34972 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
FPR2 P25090 3/20 0.35
FPR1 P21462 2/20 0.35
HDAC2 Q92769 1/20 0.35
OPRM1 P35372 1/20 0.34
CCNE1 P24864 2/20 0.34
CDK2 P24941 2/20 0.34
CDK5 Q00535 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
METAP2 P50579 2/20 0.34
METAP1 P53582 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4195445 0.93 REN (0.38) RENCNR1CNR2KDM4CHTR1A
SCHEMBL4708832 0.87 KDM4C (0.38) RENCNR1CNR2KDM4CHDAC2
SCHEMBL4186546 0.85 REN (0.36) RENCNR1CNR2KDM4CHTR1A
SCHEMBL4190961 0.85 HTR1A (0.37) RENCNR1CNR2HTR1ADRD2
SCHEMBL4197246 0.84 REN (0.36) RENCNR1CNR2KDM4CHTR1A
SCHEMBL4194046 0.84 HTR1A (0.36) RENCNR1CNR2HTR1ADRD2
Cyclohexane SCHEMBL14348272 0.81 KDM4C (0.43) KDM4CHTR1ADRD2HTR2AFPR2
SCHEMBL4195010 0.81 CXCR2 (0.36) HTR1ADRD2HTR2AFPR2FPR1
SCHEMBL4200116 0.81 HCAR1 (0.38) HTR1ADRD2HTR2AFPR2FPR1
SCHEMBL4200047 0.81 CCR2 (0.38) RENKDM4CHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 REN 4111/4885CNR1 4619/4885CNR2 4811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.